chrisvoncsefalvay/vaers-outcomes huggingface dataset:
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 61-year-old female patient (not pregnant) received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (DOSE 1, MANUFACTURER UNKNOWN), for COVID-19 immunisation; Covid-19 vaccine (DOSE 2, MANUFACTURER UNKNOWN), for COVID-19 immunisation. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2023, outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19 which included Paxlovid from 01Nov2023 to 05Nov2023.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300380582 as same patient, different drug/event.;
Flu-like symptoms started 31 hours after I received my booster shot of Moderna - body aches, fatige and exhaustion, headache, sever chills, low grade fever.  The next morning the injection site in my right arm was a hard lump, swollen, hot, red, and slightly itchy. The discomfort is localized to about 3 inches diameter. The rest of my arm is fine. The flu symptoms have resolved 24 hours after they started, but he arm is still red and itchy and swollen at the vaccine injection site.
rash to rt thigh x 3 days w/lesions seen MD 6/18/99;
Mix and Drew covid vaccine with a less amount of Saline. Vial was mixed with 1.3ml instead of 2.2 ml, Patient received a Higher concentrated dose of the vaccine itself. As per CDC patient doesn't need a second dose. Pt will be receiving a 3rd one in 01/13/2023
On 4/22/01, mother noted 2 red bumps (3 days after) vaccines. Over the next 3 days, increased in number of red hive-like spots. With father over weekend and not sure of diet or skin exposures. Had chocolate candy during this period also. Seen at clinic on 4/25/01. Alert, playful. TM with injected areas, mouth clear with no lesions. Scattered hive-like (urticaria) rash with erythema multiforme-like areas confluent on left leg scattered over trunk, face and other leg and arms. Treated with Benadryl.
Chills, upper arm ache, stomach ache, and fever (100.7) at about 11 am on Wednesday January 6, 2021.  Called employee health and went to get a COVID test
Day after injection, i experienced 100 temp. Very sore arm, sore throat, body aches, dizzy, severe headache, lethargy, joint pain  and some mild nausea. I was sick until 2/4 at around 1:00 pm.
pt came in doctor office 10/20/22  with rash , DX with erythema multiforme
p/vax pt dx w/acute pancreatitis,azotemia,anemia,leukocytosis, & hypocalcemia.Pt hospitialized & dvlped complications including respiratory insufficiency sec. to abd distention.Pt tx w/multiple IV meds,intubation,thoracentesis. Annual follow-up dated 1/17/01 provided no additional data.
PATIENT WAS SEEN AT PRIMARY CARE PROVIDER WHEN SYMPTOMS STARTED. MEMBER COMPLAINED OF EYE SWOLLEN AND WATERY EYES. PCP DISCUSSED ABOUT BELL'S PAULSY, PHARYNGITIS, AND ALLERGIC RHINITIS. PCP PRESCRIBED PREDNISONE 20MG, VALACYCLOVIR 500MG AND NATURAL TEARS(PF) .1%-.3% DROPS. MEMBER RECEIVED 2015 INFLUENZA WITH NO REACTION.
sore arm; not feeling well; muscle problems; muscle spasm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 08Apr2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset Apr2021, outcome "unknown", described as "sore arm"; MALAISE (non-serious) with onset Apr2021, outcome "unknown", described as "not feeling well"; MUSCLE DISORDER (non-serious) with onset Apr2021, outcome "unknown", described as "muscle problems"; MUSCLE SPASMS (non-serious) with onset Apr2021, outcome "unknown", described as "muscle spasm". Therapeutic measures were taken as a result of pain in extremity, malaise, muscle disorder, muscle spasms.  Additional Information: Patient received the first dose of Covid-19 vaccine yesterday April 8. She experienced a sore arm and not feeling well. She also took 2 extra strength Tylenol this morning and 2 in the afternoon. She has muscle problems, muscle spasm on lower back and hasn't taken muscle relaxant in a couple of days. Asked when it is safe to take the muscle relaxant and how long is she going to wait.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
a little headache; a achy; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team.  A female patient received BNT162b2 (BNT162B2), as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE), for COVID-19 Immunization, reaction(s): "A little headache", "a achy". The following information was reported: HEADACHE (non-serious), outcome "unknown", described as "a little headache"; PAIN (non-serious), outcome "unknown", described as "a achy".  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
first of two patient who received Pneumococcal 23 that complained of swelling, and unable to move arm due to the pain.  Both patients were seen on the same day, symptoms started the same day and the lot of the vaccine were the same.
Acute to subacute no hemorrhagic infarct,   @superolateral thalamus,   Measures 1.5. X 1.4.   Recovering left side paralysis
This spontaneous report was received from a physician refers to multiple patients of unknown age and gender. Concurrent conditions and medical history were not reported. On unspecified dates, the patients were vaccinated with improperly stored doses (temperature excursion: 28-OCT-2015 to 13.17 F and 11-SEP-2015 to 13.13 F, time frame: worst case 10 minutes each occasion) of PROQUAD with lot/batch # L019996, expiry date 02-DEC-2016 and lot/batch # L033962, expiry date 28-FEB-2017 (dose, dose number, vaccination site and route of administration not provided). There was no previous temperature excursion. Concomitant therapies were not reported. No adverse effects were reported. Product quality complaint (PQC) was not involved. This is one of the several reports from same reporter link. Additional information has been requested.
Within hours of the vax, the child developed a fever of 104 plus. That evening he was seen in an ER where a complete blood count was done. His white blood cell count was found to be 16,000. Blood and urine cultures were ordered but the reporter did not provide results. He was treated with Rocephin. The next day, the child was seen by the physician who also treated the pt with Rocephin. Another blood count was done with white blood cell count results remaining at 16,000. The mother treated the child with Motrin. A copy of this report was forwarded to Merck.
On 8/2/00, the pt developed a fever of 100.8, cranky, and redness at injection site. On 8/3/00, the pt developed a rash on his face and body.
feeling very dizzy; Very sick feeling; low grade fever; Vertigo; My head does not feel like it's attached to my body; This is a spontaneous report from a contactable consumer (patient). A 73-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 21Jan2021 12:30 at single dose in left arm for COVID-19 immunisation. Patient age at vaccination was 73 years. No other vaccine was given within 4 weeks prior to the COVID vaccine. Medical history included heart stent. The patient has no known allergies. Concomitant medications included lisinopril, clopidogrel besylate (CLOPIDOGREL), metoprolol, rosuvastatin. On 21Jan2021 16:00 the patient started feeling very dizzy, vertigo, she stated: 'It's two days now I still feel it, very sick feeling, had a low grade fever, my head does not feel like it's attached to my body'. No treatment was given for the events. The events had not resolved. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, has not been tested for COVID-19.  Information about Batch/Lot number has been requested.
"Feels like something is hitting inside my head - and it feels worse when people are talking". Mom called - will pick up. Later says thigh hurts - but head feels better. Inst. mom to call MD with further problems. Mom picked up @ 12.10
Shortly after the vaccine I developed red, burning hot feet which persisted off and on for about 3 months.  My dermatologist  diagnosed me with  Erythromelalgia and perscribed Neurotin and finally within the last 10 days since the vaccination has the symptoms finally has seem to be getting better and are diminshing  It generally occurs at night but happens periodically throughtout the day as well.
Dizziness, acute swelling of the face, eyes and throat and difficulty breathing about a half an hour after the injection.
Information has been received from a nurse concerning a pt who was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine. Subsequently the pt developed an allergic like reaction post vaccination. The reaction included a swollen, large red area about 6 inches in diameter around the injection site. The pt sought unspecified medical attention. At the time of this report, the outcome was unk. Additional information has been requested.
Information has been received from a 67 year old male who on 11/18/03 was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine. Shortly after receiving the vaccination, on approximately 11/18/03, the pt said that his arm swelled up from his shoulder down to his elbow. He also reported his arm was painful and he could not sleep on the swollen arm. The pt went to his physician who prescribed antibiotics to treat the swelling.  The pt said that he took the medicine for 2 days, his swelling went down and he is doing well.  The event abated and the pt recovered. It was noted that therapy with pneumococcal 23v polysaccharide vaccine was "discontinued". A product quality complaint was not involved.  Information was received from a woman in a physician's office which indicated that she had no information and that the vaccination was not given at her office. Information was received from a RN which indicated that the pt experienced an adverse event (not further specified) from pneumococcal 23v polysaccharide vaccine. Additional information has been requested.
Fever; Having reactions to the second dose of the Pfizer vaccine; This is a spontaneous report from a contactable consumer or other non hcp.  A female patient of an unspecified age received bnt162b2 (COVID Vaccine, formulation: solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date (an unspecified age) as DOSE 2, SINGLE for covid-19 immunisation.  The patient's medical history and concomitant medications were not reported. The patient previously took ( COVID Vaccine, formulation: solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date (an unspecified age) as DOSE 1, SINGLE for covid-19 immunisation. On an unspecified date, the patient experienced fever, having reactions to the second dose of the pfizer vaccine. The outcome of the events was unknown.  Information on the lot/ batch number has been requested.
Swelling of the face, eyelids. Hives on face, fore arms, and legs.  Lots of itching.
Weakness, unable to walk on their own, elavated blood pressure and heart rate.  Treatment: extended monitoring, standard treatment for syncope.  Husband was called for assistance and recommended trip to emergency room. Recomended rest and time off work. Patient's place of employment will give 2 days to recover.
25 minutes after receiving vaccine, patient was wheezing, complained of chest tightness and was flushed. Utilized own inhaler. Pulse 100, pulse ox 100%. At 15:55, gave 50 mg IM Benadryl. BP 140/88. At 16:00, gave EpiPen. EMS called. 16:10, patient stated she was feeling "better," and stated "doesn't feel tight in my throat." Wheezing resolved. Transported to emergency department.
pt recvd vax & lab eval revealed a neg titer for mumps; f/u info revealed that the test performed was for complement-fixation rather than a IGG test for mumps; No further details were provided;
Had vaccine and still got them/Suspected vaccination failure; still got them. Nasty, nasty and sore; sore; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and pain. On an unknown date, the outcome of the vaccination failure, shingles and pain were unknown.   It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingles vaccine.  Additional details were provided as follows: The case was reported by patient. The age at vaccination was not reported. The patient had the vaccine and still got shingles.  The patient stated that it was nasty and sore. This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles not reported.
PATIENT IS A PHYSICIAN, AND SHE THOUGHT HER SIDE EFFECTS WERE SEVERE ENOUGH TO REPORT. PATIENT COMPLAINED OF SEVERE SWELLING AND REDNESS THAT WENT AROUND THE ENTIRE  CIRCUMFERENCE OF HER LEFT UPPER ARM. SHE ALSO EXPERIENCED EXTREME CHILLS AND FEVER AND SAID THAT IT TOOK HER SEVERAL HOURS TO GET COMFORTABLY WARM. SHE EXPERIENCED SEVERE MALAISE FOR SEVERAL DAYS AND WAS NOT ABLE TO DO ANYTHING AT HOME. HER SIDE EFFECTS WERE SEVERE ENOUGH TO LEAD HER TO QUESTION GETTING THE SECOND DOSE. SHE IS NOT SURE IF SHE WILL GET THE DOSE. AS A PHYSCIAN, SHE THOUGHT HER SIDE EFFECTS WERE MORE SEVERE THAN WHAT IS TYPICALLY EXPERIENCED AFTER A VACCINATION. SHE SELF-MONITORED HER SYMPTOMS UNTIL SHE RECOVERED AFTER A FEW DAYS.
After Modena vaccination first dose back of the hand  started allergy,  red large irregular spot allover, very itchy, both legs weak, couldn't lift leg when walking.  After 2nd dose allergy became much more severe.  Red large irregular spot also appeared allover body skin,  allover back, legs, arms. On March 6, 2021 the legs were too weak hard to go on stairs. On March 7, 2021 went to the ER. After discharged on March 9, 2021, left leg became weak, right leg more severe,  walking became unbalanced when had to walk.  All over body weak, palpitation short of breath during activity, had to lie down. I'm an acupuncture doctor, already couldn't work, couldn't drive.
9/12: Called to report covid positive result from 9/10/21. Still having cough, chills, fever, body aches, loss of taste. She is currently quarantining/isolating. Felt like she got it from her husband. Discussed f/u with PCP. Discussed she will need to quarantine/isolate x10 days since s/s first appeared and will need to be 24hrs passed since last fever without use of fever-reducing medications. States her last day of work was 9/7/21. She normally works Tues-Fri and immediately left work when she found out her husband was positive. She has not had contact with her coworkers outside of work. Eats in her breakroom at work, but tables are separated with designated area to sit. She has been taking OTC cold/flu medicines, which has been helping. instructed to call hotline when released from quarantine and discussed RTW clearance through when s/s improved/resolved. not part of study- antibodies testing ordered.  9/10: reporting cough, chills, low grade fever, body aches. Onset 9/9/21. had an exposure to husband who tested positive on 9/7/21. Last close contact was on 9/7/21. currently in quarantine, if tests positive her scheduled post 5-day test for 9/12 will need to be cancelled.  9/7: called hotline to report that she just found out today (9/7) that her husband had tested positive for covid. was at work but left work. last direct contact with her husband was this morning. is asymptomatic. instructed that she needs to quarantine and isolate from her husband which she states she can do until she is tested for covid and gets her test results back. parents also live with her and her husband and they are also able to isolate from one another. given community hotline number for her parents for further instructions and guidance. scheduled at on 9/12 for covid testing for post direct exposure. instructed to call the hotline should she become symptomatic and we can schedule her for testing earlier. instructed to inform her manager she will be off of work and to call hotline with her test results for further instructions/ guidance.
broke out in a rash under the chest, stomach and back; blistering areas that bled; red rash under the skin that spread; This is a spontaneous report from a contactable consumer (patient). A 53-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: FA7485), administered in the left arm on 02Sep2021 at 15:30 (at the age of 53-years-old) at dose number unknown, single for COVID-19 immunisation. Medical history included patient was allergic to multiple meds and foods, latex; polycystic ovarian syndrome (PCOS); endometriosis; arthritis and lupus; prior to vaccination the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included rabeprazole sodium (ACIPHEX) and metoprolol, both reported as other medications the patient received within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On the 3rd day, on 05Sep2021, patient broke out in a rash under the chest, stomach and back; blistering areas that bled and a red rash under the skin that spread. Ended up in urgent care with prednisone and a steroid cream (which patient ended up having another reaction too). On day 7, the patient still had the rash after 3 days of meds. The events were reported as non-serious. The adverse event resulted in doctor or other healthcare professional office/clinic visit and in emergency room/department or urgent care. A treatment was received for the adverse event and included steroid. The patient had not recovered from the events.
Information has been received from a Doctor of pharmacy concerning a 67 year old female patient with no drug reactions/allergies and hypercholesterolemia who on 18-FEB-2009 was vaccinated with single dose of ZOSTAVAX (Merck) (lot # 663177/1413X) SQ at the pharmacy. Concomitant therapy included statin (unspecified). Since 19-FEB-2009 or 20-FEB-2009 the patient had developed intermittent muscle pain of the left arm and shoulder. The patient had contacted pharmacist for medical attention. No lab diagnostics were performed. The patient's intermittent muscle pain of the left arm and shoulder persisted. This is one of several reports from the same source. Additional information has been requested.
Pentacel- given DTap/IPV component only. Not ACTHIB component  No S/S noted
had soreness on his arm after 1st dose; This is a spontaneous report from a Pfizer-sponsored program. A contactable male consumer (Patient) reported that: A male of unspecified age received first dose of bnt162b2 (BNT162B2, Formulation: solution for injection, Batch/Lot Number not reported) via an unspecified route of administration, administered on 29Jan2021 as dose 1, single for covid-19 immunisation. The patient medical history and concomitant medications not reported. On 29Jan2021 patient experienced soreness on his arm. The patient received took 2 Advil and 1 Tylenol an hour before his 2nd dose. The outcome of event was unknown.  Follow-up attempts completed. No further information expected. Information about lot/batch number cannot be obtained
Patient called the pharmacy on 12/02/2021 to notify us that he had received the booster shot too early, it had only been 3 months since his second covid shot
patient was feeling dizzy and head hurt about 5 minutes after administration. He took his bloop pressure which was high 160/98.  I kept monitoring the patient and had slight rash on chest which went away and after 5 minutes time . Then started to feel  itchy but no rash appeared. after about 20 minutes didn't feel better so gave 25mg benadryl capsule and called 911. EMS took patient to the hospital because patient said tongue felt heavy.
6mins post vaccination pt presented w/ Nausea, vomiting, flushing/sweating, dizziness and pt appear pale. Vitals: 78/46, 62, 18, Temp 97.4 Pt stabilized and released from the vaccination site.
MMR on 11/8/99, rash started 11/20/99, then hives, later, Sat (11/20/99).
About 4 hours after injections, the patient started to experience pain, swelling, redness, and stiffness at the injection site and reached down to her elbow. Patient treated with ibuprofen. Patient states that the redness was mostly around the Fluad injection which was lower on her deltoid muscle. The patient stated that the area started to look better today with less redness, pain, and swelling.
Patient presented for second COVID-19 vaccine today 3/11/21, but patient had developed pruritic, erythematous lesions on bilateral arms approximately one week following administration of first vaccine on 2/11/21. Pt reported lesions were increasing in size and spreading. 2nd vaccine dose was not given today. Patient was referred to walk-in clinic and received prescription for 10-day course of PO steroids and is scheduled to follow up with PCP on 4/1/21.
Patient received the full vial of vaccine undiluted in one dose  ED visit 10/01/2021 ED  10/02/2021  Patient presented with fever, aches, and fatigue. No treatment administered, instructed to monitor patient and return if any adverse events noted.
Pt recv vax on 10/21/98; on 10/22/98 pt exp left facial droop & eyelid, LA swelling, pain & swelling of right body
This spontaneous report was received from a physician referring to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, drug reactions/allergies and concomitant medications were not provided. On an unknown date ("around 13 and 14 years old"), the patient was vaccinated with two doses of GARDASIL injection (strength, dose, route of administration, lot # and expiry date were not reported) for prophylaxis. It was unspecified if the doses were administered on schedule. No adverse effect was reported. No additional information was provided. There was no product quality complaint (PQC) reported.
Patient came in for first dose of Pfizer for COVID-19 vaccination. She was given the Pfizer monovalent with use-by date of 10/21/2022. Error was discovered during charting after patient had left the clinic. Patient was called to inform them of the situation, as our office had called a Pfizer representative who needs to determine if stability is still acceptable. We informed her that we were waiting for his response, and offered her to wait on his answer or come in for a new vaccination per CDC guidelines. She decided to wait, and a final decision is pending.